Literature DB >> 35088229

The interplay of long noncoding RNA HULC with microRNA-128-3p and their correlations with lipid level, stenosis degree, inflammatory cytokines, and cell adhesion molecules in coronary heart disease patients.

Xuting Zhu1, Jun Hu1, Lianhong Xie2.   

Abstract

BACKGROUND: Long noncoding RNA HULC (lnc-HULC) and its target microRNA-128-3p (miR-128-3p) regulate endothelial cell function, blood lipid level, and inflammatory cytokine production, which are involved in the pathogenesis of coronary heart disease (CHD). Based on the above information, this study intended to further investigate the correlation between lnc-HULC and miR-128-3p, as well as their clinical values for CHD management.
METHODS: Totally, 141 CHD patients and 70 controls were enrolled. Lnc-HULC and miR-128-3p in peripheral blood mononuclear cells were detected by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Serum inflammatory cytokines and cell adhesion molecules were further determined by enzyme-linked immunosorbent assay (ELISA) in CHD patients.
RESULTS: Lnc-HULC was upregulated, while miR-128-3p was downregulated in CHD patients than in controls (both P < 0.001). The ROC curve further displayed that lnc-HULC (AUC: 0.906, 95% CI: 0.867-0.945) and miR-128-3p (AUC: 0.814, 95% CI: 0.756-0.873) had the potential of discriminating CHD patients from controls. Regarding the correlation between lnc-HULC and miR-128-3p, lnc-HULC was negatively associated with miR-128-3p in CHD patients (rs =  - 0.307, P < 0.001), but this association was not observed in controls (rs =  - 0.155, P = 0.199). Furthermore, it was discovered that upregulated lnc-HULC was associated with elevated blood lipid levels (TG, LDL-C), inflammatory cytokines (interleukin (IL)-1β, IL-17A), cell adhesion molecules (VCAM-1), and Gensini score (all P < 0.05) in CHD patients. Meanwhile, miR-128-3p was negatively associated with blood lipid level (LDL-C), inflammatory cytokines (TNF-α, IL-1β, IL-6), cell adhesion molecules (VCAM-1, ICAM-1), and Gensini score (all P < 0.05) in CHD patients.
CONCLUSION: Lnc-HULC and its target miR-128-3p relate to lipid level, stenosis degree, inflammatory cytokines, and cell adhesion molecules in CHD patients.
© 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Coronary heart disease; Disease risk and severity; Inflammatory cytokine; Lnc-HULC; miR-128-3p

Year:  2022        PMID: 35088229     DOI: 10.1007/s11845-021-02900-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  22 in total

Review 1.  Metabolomics in early detection and prognosis of acute coronary syndrome.

Authors:  Mohammad Pouralijan Amiri; Maryam Khoshkam; Reza M Salek; Reza Madadi; Ghassem Faghanzadeh Ganji; Ali Ramazani
Journal:  Clin Chim Acta       Date:  2019-03-27       Impact factor: 3.786

Review 2.  Diagnosis and management of acute coronary syndrome: an evidence-based update.

Authors:  Jennifer N Smith; Jenna M Negrelli; Megha B Manek; Emily M Hawes; Anthony J Viera
Journal:  J Am Board Fam Med       Date:  2015 Mar-Apr       Impact factor: 2.657

Review 3.  Recurrent atherosclerosis complications as a mechanism for stent failure.

Authors:  Ioannis Andreou; Peter H Stone; Ignatios Ikonomidis; Dimitrios Alexopoulos; Manel Sabaté
Journal:  Hellenic J Cardiol       Date:  2019-04-26

4.  Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.

Authors:  Ming Cui; Zelin Xiao; Yue Wang; Minying Zheng; Tianqiang Song; Xiaoli Cai; Baodi Sun; Lihong Ye; Xiaodong Zhang
Journal:  Cancer Res       Date:  2015-01-15       Impact factor: 12.701

5.  1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry.

Authors:  Manesh R Patel; Bjarne Linde Nørgaard; Timothy A Fairbairn; Koen Nieman; Takashi Akasaka; Daniel S Berman; Gilbert L Raff; Lynne M Hurwitz Koweek; Gianluca Pontone; Tomohiro Kawasaki; Niels Peter Rønnow Sand; Jesper M Jensen; Tetsuya Amano; Michael Poon; Kristian A Øvrehus; Jeroen Sonck; Mark G Rabbat; Sarah Mullen; Bernard De Bruyne; Campbell Rogers; Hitoshi Matsuo; Jeroen J Bax; Jonathon Leipsic
Journal:  JACC Cardiovasc Imaging       Date:  2019-03-17

Review 6.  Acute coronary syndrome.

Authors:  Nader Makki; Theresa M Brennan; Saket Girotra
Journal:  J Intensive Care Med       Date:  2013-09-18       Impact factor: 3.510

7.  Evidence in Guidelines for Treatment of Coronary Artery Disease.

Authors:  Sida Jia; Yue Liu; Jinqing Yuan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  China cardiovascular diseases report 2018: an updated summary.

Authors:  Li-Yuan Ma; Wei-Wei Chen; Run-Lin Gao; Li-Sheng Liu; Man-Lu Zhu; Yong-Jun Wang; Zhao-Su Wu; Hui-Jun Li; Dong-Feng Gu; Yue-Jin Yang; Zhe Zheng; Sheng-Shou Hu
Journal:  J Geriatr Cardiol       Date:  2020-01       Impact factor: 3.327

9.  Overexpression of lncRNA HULC Attenuates Myocardial Ischemia/reperfusion Injury in Rat Models and Apoptosis of Hypoxia/reoxygenation Cardiomyocytes via Targeting miR-377-5p through NLRP3/Caspase‑1/IL‑1β Signaling Pathway Inhibition.

Authors:  Huiqing Liang; Fangjiang Li; Huixian Li; Rui Wang; Meiling Du
Journal:  Immunol Invest       Date:  2020-07-17       Impact factor: 3.657

Review 10.  Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection.

Authors:  Nikolaos Kosmas; Antonis S Manolis; Nikolaos Dagres; Efstathios K Iliodromitis
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.